These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2408746)

  • 1. DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells.
    D'Incalci M; Covey JM; Zaharko DS; Kohn KW
    Cancer Res; 1985 Jul; 45(7):3197-202. PubMed ID: 2408746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells.
    Covey JM; D'Incalci M; Tilchen EJ; Zaharko DS; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5511-7. PubMed ID: 2428479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
    Wilson VL; Jones PA; Momparler RL
    Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cells.
    Limonta M; Colombo T; Damia G; Catapano CV; Conter V; Gervasoni M; Masera G; Liso V; Specchia G; Giudici G
    Leuk Res; 1993 Nov; 17(11):977-82. PubMed ID: 7694001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
    Grant S; Rauscher F; Margolin J; Cadman E
    Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
    Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
    Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High degree of resistance to 5-aza-2'-deoxycytidine in L1210 cells in vitro associated with almost complete loss of deoxycytidine kinase activity.
    Veselý J
    Neoplasma; 1987; 34(6):713-20. PubMed ID: 2448662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
    Veselý J; Cihák A
    Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of 5-aza-2'-deoxycytidine phosphorylation in mouse spleen and L1210 leukemic cell extracts.
    Veselý J; Cihák A
    Neoplasma; 1980; 27(2):121-7. PubMed ID: 6156420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Veselý J; Pískala A
    Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
    Raynal NJ; Momparler LF; Rivard GE; Momparler RL
    Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo.
    Veselý J; Pískala A
    Cancer Res; 1984 Nov; 44(11):5165-8. PubMed ID: 6207913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
    Chabot GG; Momparler RL
    Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
    Momparler RL; Momparler LF; Samson J
    Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
    Lu LJ; Randerath K
    Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).
    Bowden GT; Garcia D; Peng YM; Alberts DS
    Cancer Res; 1982 Jul; 42(7):2660-5. PubMed ID: 7083158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
    Pierson V; Pierre A; Pommier Y; Gros P
    Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.